Skip to main content
PMC home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 1999 May;80(3):F213–F216. doi: 10.1136/fn.80.3.f213

Effect of multiple courses of antenatal corticosteroids on pituitary-adrenal function in preterm infants

P Ng, G Wong, C Lam, C Lee, T Fok, M Wong, K Ma
PMCID: PMC1720941  PMID: 10212084

Abstract

AIM—To evaluate the pituitary-adrenal function of preterm infants whose mothers received multiple courses (8 or more doses) of antenatal dexamethasone.
METHODS—The pituitary-adrenal function of 14 preterm infants whose mothers received eight or more doses of antenatal dexamethasone were assessed using the human corticotrophin releasing hormone (hCRH) stimulation test when 7 days (n = 14) and 14 days old (n= 12). During each test, blood samples were taken at 0 (baseline), 15, 30 and 60 minutes after an intravenous bolus dose of hCRH (1 µg/kg). The corresponding hormone concentrations were compared between days 7 and 14, and with various associated factors.
RESULTS—The baseline (0 min) plasma adrenocorticotrophic hormone concentration was significantly higher at day 14 than at day 7 (p= 0.036). None of the corresponding poststimulation (15, 30, and 60 min) hormone concentrations was significantly different between the two time epochs. When the association between the hormone concentrations and the number of antenatal dexamethasone doses received by the mothers was assessed, a significant negative correlation was observed in serum cortisol concentrations at 15 and 30 min on day 14 (r = −0.59, p = 0.04 and r = −0.60, p = 0.039,respectively).
CONCLUSIONS—The absence of a significant difference in poststimulation hormone concentrations between days 7 and 14 in this cohort of infants, and the similarity of their hormone responses with those of older children and adults, suggests that no severe pituitary-adrenal suppression had occurred. None the less there was evidence of mild adrenal suppression in some of the treated infants. Vigilance in monitoring blood pressure, electrolytes and signs of adrenal suppression in infants whose mothers receive multiple courses (8 or more doses) of antenatal dexamethasone is required, as some of them might have diminished adrenal reserve.



Full Text

The Full Text of this article is available as a PDF (82.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bauer C. R., Morrison J. C., Poole W. K., Korones S. B., Boehm J. J., Rigatto H., Zachman R. D. A decreased incidence of necrotizing enterocolitis after prenatal glucocorticoid therapy. Pediatrics. 1984 May;73(5):682–688. [PubMed] [Google Scholar]
  2. Crowley P. A. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol. 1995 Jul;173(1):322–335. doi: 10.1016/0002-9378(95)90222-8. [DOI] [PubMed] [Google Scholar]
  3. Goji K. The corticotropin-releasing hormone test in normal short children: comparison of plasma adrenocorticotropin and cortisol responses to human corticotropin-releasing hormone and insulin-induced hypoglycemia. Acta Endocrinol (Copenh) 1989 Mar;120(3):390–394. doi: 10.1530/acta.0.1200390. [DOI] [PubMed] [Google Scholar]
  4. Leviton A., Kuban K. C., Pagano M., Allred E. N., Van Marter L. Antenatal corticosteroids appear to reduce the risk of postnatal germinal matrix hemorrhage in intubated low birth weight newborns. Pediatrics. 1993 Jun;91(6):1083–1088. [PubMed] [Google Scholar]
  5. Ng P. C., Blackburn M. E., Brownlee K. G., Buckler J. M., Dear P. R. Adrenal response in very low birthweight babies after dexamethasone treatment for bronchopulmonary dysplasia. Arch Dis Child. 1989 Dec;64(12):1721–1726. doi: 10.1136/adc.64.12.1721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ng P. C., Wong G. W., Lam C. W., Lee C. H., Fok T. F., Wong M. Y., Wong W., Chan D. C. Pituitary-adrenal suppression and recovery in preterm very low birth weight infants after dexamethasone treatment for bronchopulmonary dysplasia. J Clin Endocrinol Metab. 1997 Aug;82(8):2429–2432. doi: 10.1210/jcem.82.8.4152. [DOI] [PubMed] [Google Scholar]
  7. Ng P. C., Wong G. W., Lam C. W., Lee C. H., Wong M. Y., Fok T. F., Wong W., Chan D. C. Pituitary-adrenal response in preterm very low birth weight infants after treatment with antenatal corticosteroids. J Clin Endocrinol Metab. 1997 Nov;82(11):3548–3552. doi: 10.1210/jcem.82.11.4392. [DOI] [PubMed] [Google Scholar]
  8. Schlaghecke R., Kornely E., Santen R. T., Ridderskamp P. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. N Engl J Med. 1992 Jan 23;326(4):226–230. doi: 10.1056/NEJM199201233260403. [DOI] [PubMed] [Google Scholar]
  9. Sinclair J. C. Meta-analysis of randomized controlled trials of antenatal corticosteroid for the prevention of respiratory distress syndrome: discussion. Am J Obstet Gynecol. 1995 Jul;173(1):335–344. doi: 10.1016/0002-9378(95)90223-6. [DOI] [PubMed] [Google Scholar]
  10. Van Marter L. J., Leviton A., Kuban K. C., Pagano M., Allred E. N. Maternal glucocorticoid therapy and reduced risk of bronchopulmonary dysplasia. Pediatrics. 1990 Sep;86(3):331–336. [PubMed] [Google Scholar]
  11. Wittekind C. A., Arnold J. D., Leslie G. I., Luttrell B., Jones M. P. Longitudinal study of plasma ACTH and cortisol in very low birth weight infants in the first 8 weeks of life. Early Hum Dev. 1993 Jul;33(3):191–200. doi: 10.1016/0378-3782(93)90145-k. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood. Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES